Category: Biomarkers
Middle East Biomarkers
-
2023 Oman Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Kuwait Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Iraq Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Iran Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Lebanon Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Qatar Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
Middle East Liquid Biopsy Market - By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In-Situ Hybridization (FISH), Other Technologies); By Work Flow (Sample Preparation, Library Preparation, Sequencing, Data Analysis); By Usage (Research Use Only (RUO), Clinical); By Sample (Blood, Urine, Saliva); By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Other Circulating Biomarkers); By Product (Tests/Services, Kits and Consumables, Instruments), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Only (RUO), Clinical); By Sample (Blood, Urine, Saliva); By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Other Circulating Biomarkers); By Product (Tests/Services, Kits and Consumables, Instruments), ... Read More
-
Global Metabolomics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product and Services (Metabolomics Instrument, Metabolomics bioinformatics tools and services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Metabolic Disorders), Application (Biomarker Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
... Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Market Overview: The scientific study of chemical processes, including metabolites, is known as ... Read More
-
Global Biomarkers Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type (Molecular, Radiographic, Histologic, Physiologic), Application (Disease Susceptibility/Risk, Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), Disease (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa)
... Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa) Market Overview: Biomarkers are biological measures used to conduct a diagnostic evaluation, such as blood pressure or cholesterol level, as well ... Read More
-
Global Liquid Biopsy Market, By Sampling Type (Blood Sampling, Urine Sampling, Saliva Sampling, and Other Tissue Fluids Sampling), By Product and Service (Assay Kits, Instruments, and Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, ... Read More
-
Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Other Cancer Biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, and Other Cancers), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 ... Read More
-
Middle East Liquid Biopsy Market - Country Analysis: Focus on Product, Technology, Indication, Sample, Workflow, Circulating Biomarker, Usage, and Country Data - Analysis and Forecast, 2022-2032
... the Middle East liquid biopsy market was valued at $43.7 million, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The Middle East ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More